All posts by : Felistas

Five years since COVID-19 started upending the world, the virus is still infecting and killing people across the globe—though at far lower levels than at the height of the pandemic.

People who drink coffee in the morning have a lower risk of dying from cardiovascular disease and a lower overall mortality risk compared to all-day coffee drinkers, according to research published in the European Heart Journal.

A new study, co-led by a University of Massachusetts Amherst researcher, set out to identify the most effective strategies for helping people quit vaping. The findings, published in the Cochrane Database of Systematic Reviews, suggest that varenicline, a prescription medication often used to help people stop smoking, and text message-based interventions can help people quit.

Regular physical activity before a cancer diagnosis may lower the risks of both disease progression and death, suggests research published online in the British Journal of Sports Medicine.

Basking too long in a sauna may put bathers at risk of heat stroke, particularly if they haven’t drunk enough water beforehand, warn doctors in the journal BMJ Case Reports, after treating a woman whose condition required admission to hospital.

Children and young people with high levels of mental health needs are struggling to receive the help they need, or to have their difficulties recognized, according to a new study.

A recent study from the McGovern Institute for Brain Research shows how interests can modulate language processing in children’s brains and paves the way for personalized brain research.

For dialysis-dependent patients treated for osteoporosis, denosumab is associated with a greater preventive effect on fractures but an increased risk for major adverse cardiovascular events (MACE) compared with oral bisphosphonates, according to a study published online Jan. 7 in the Annals of Internal Medicine.

Individuals in the lowest quintile of birth weight appear to have an increased risk for subsequent chronic obstructive pulmonary disease (COPD), according to a study published online Dec. 11 in BMJ Open Respiratory Research.

For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.